TrialEuropean child & adolescent psychiatry2021

Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial.

Maryam Rafeiy-Torghabeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.